Published in Dialogues Clin Neurosci on January 01, 2011
Functional magnetic resonance imaging during emotion recognition in social anxiety disorder: an activation likelihood meta-analysis. Front Hum Neurosci (2013) 1.02
Decreased saliency processing as a neural measure of Barratt impulsivity in healthy adults. Neuroimage (2012) 1.01
Hippocampal shape abnormalities of patients with childhood-onset schizophrenia and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2013) 0.92
How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav (2013) 0.87
Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury. PLoS One (2014) 0.86
Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol (2014) 0.83
Neural correlates of a computerized attention modification program in anxious subjects. Soc Cogn Affect Neurosci (2013) 0.82
The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning. Physiology (Bethesda) (2015) 0.81
A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues Clin Neurosci (2015) 0.81
Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders. Transl Psychiatry (2012) 0.81
Adult-like action potential properties and abundant GABAergic synaptic responses in amygdala neurons from newborn marmosets. J Physiol (2012) 0.80
Functional MRI in the investigation of blast-related traumatic brain injury. Front Neurol (2013) 0.80
Gender Differences in the Neurobiology of Anxiety: Focus on Adult Hippocampal Neurogenesis. Neural Plast (2016) 0.77
Distinct molecular components for thalamic- and cortical-dependent plasticity in the lateral amygdala. Front Mol Neurosci (2014) 0.76
High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav (2016) 0.75
Functional neuroanatomy in panic disorder: Status quo of the research. World J Psychiatry (2017) 0.75
Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing. Soc Cogn Affect Neurosci (2013) 0.75
How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci (2002) 15.88
Neural systems supporting interoceptive awareness. Nat Neurosci (2004) 11.88
Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage (2002) 9.66
Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry (2007) 8.87
Extinction learning in humans: role of the amygdala and vmPFC. Neuron (2004) 8.63
Oxytocin, vasopressin, and the neurogenetics of sociality. Science (2008) 5.53
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci (2002) 5.45
Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci (2003) 4.91
Stress, memory and the amygdala. Nat Rev Neurosci (2009) 4.57
Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron (1998) 4.06
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci (2006) 3.78
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry (2004) 3.64
Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion (2010) 3.23
What does the amygdala contribute to social cognition? Ann N Y Acad Sci (2010) 3.11
Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry (1999) 2.62
Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry (2002) 2.49
Emotional perception: meta-analyses of face and natural scene processing. Neuroimage (2010) 2.40
Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One (2009) 2.37
Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value. Nat Neurosci (2004) 2.25
Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci (2003) 2.21
Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry (2006) 2.11
Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am (2010) 2.08
Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology (2010) 1.98
Oxytocin, vasopressin and sociality. Prog Brain Res (2008) 1.94
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Classical fear conditioning in functional neuroimaging. Curr Opin Neurobiol (2000) 1.74
Re-valuing the amygdala. Curr Opin Neurobiol (2010) 1.72
Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res (2008) 1.59
The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry (2010) 1.40
The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology (2005) 1.38
Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry (2009) 1.35
fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) (2006) 1.30
Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder. Psychiatry Res (2004) 1.22
Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand (2003) 1.21
Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combat-related posttraumatic stress disorder. Psychopharmacol Bull (2007) 1.17
Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.15
Reduced hippocampal and amygdala activity predicts memory distortions for trauma reminders in combat-related PTSD. J Psychiatr Res (2010) 1.14
Neural, electrodermal and behavioral response patterns in contingency aware and unaware subjects during a picture-picture conditioning paradigm. Neuroscience (2008) 1.09
Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. Gastroenterology (2005) 1.07
Functional connectivity in fronto-subcortical circuitry during the resting state in obsessive-compulsive disorder. Neurosci Lett (2010) 1.06
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry (1990) 1.06
Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry (2007) 1.05
Brain imaging in anxiety disorders. Expert Rev Neurother (2004) 1.05
Neuroimaging in obsessive-compulsive disorder. Expert Rev Neurother (2009) 1.05
Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res (2004) 1.04
D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry (2009) 1.04
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry (1991) 1.03
Duration of posttraumatic stress disorder predicts hippocampal grey matter loss. Neuroreport (2009) 1.02
Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol (2005) 1.02
Neurocircuitry of anxiety disorders. Curr Psychiatry Rep (2003) 1.01
Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01
Weaving the (neuronal) web: fear learning in spider phobia. Neuroimage (2010) 1.00
Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. Psychophysiology (2010) 1.00
The neural correlates of emotional memory in posttraumatic stress disorder. Biol Psychiatry (2010) 0.98
Neural correlates of recovery from post-traumatic stress disorder: a longitudinal fMRI investigation of memory encoding. Neuropsychologia (2011) 0.97
Functional imaging of mood and anxiety disorders. J Neuroimaging (2006) 0.96
An fMRI investigation of memory encoding in PTSD: influence of symptom severity. Neuropsychologia (2008) 0.95
Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry (1999) 0.94
Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage (2006) 0.92
Cingulate cortex: its role in Pavlovian conditioning. J Comp Physiol Psychol (1982) 0.90
Imaging in posttraumatic stress disorder. Curr Opin Psychiatry (2011) 0.89
Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology (2011) 0.86
Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. Hum Brain Mapp (2009) 0.86
Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res (2003) 0.85
Limbic thalamic, cingulate cortical and hippocampal neuronal correlates of discriminative approach learning in rabbits. Behav Brain Res (1996) 0.84
Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest Suppl (2001) 0.84
An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia. CNS Spectr (2009) 0.81
Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology (Berl) (2007) 0.80
Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. J Psychiatr Res (2010) 0.80
The role of neuroimaging for the diagnosis and treatment of anxiety disorders. Depress Anxiety (2008) 0.79
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder. Pharmacopsychiatry (2009) 0.78
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. J Psychopharmacol (2010) 0.78
Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers. Psychiatry Res (2010) 0.76
Impact of state and trait anxiety on the panic response to CCK-4. J Neural Transm (Vienna) (2008) 0.76
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI. J Neurosci (2011) 1.81
EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage (2008) 1.24
Reduced early auditory evoked gamma-band response in patients with schizophrenia. Biol Psychiatry (2009) 1.11
Theta burst stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry (2008) 1.04
Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry (2007) 1.01
Neural correlates (ERP/fMRI) of voluntary selection in adult ADHD patients. Eur Arch Psychiatry Clin Neurosci (2009) 0.99
Insufficient depression treatment in outpatient settings. Ger Med Sci (2004) 0.98
Regional networks underlying interhemispheric connectivity: an EEG and DTI study in healthy ageing and amnestic mild cognitive impairment. Hum Brain Mapp (2009) 0.97
Evaluation of sham transcranial direct current stimulation for randomized, placebo-controlled clinical trials. Brain Stimul (2013) 0.96
Combined distributed source and single-trial EEG-fMRI modeling: application to effortful decision making processes. Neuroimage (2009) 0.96
Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by low resolution electromagnetic tomography (LORETA). Psychiatry Res (2002) 0.95
Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder. Int J Psychophysiol (2006) 0.95
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res (2005) 0.94
EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol (2003) 0.94
Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage (2002) 0.90
Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses. J Psychiatr Res (2007) 0.89
A controlled single case study with repeated fMRI measurements during the treatment of a patient with obsessive-compulsive disorder: testing the nonlinear dynamics approach to psychotherapy. World J Biol Psychiatry (2009) 0.88
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. J Psychiatr Res (2009) 0.88
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. Psychiatry Res (2007) 0.88
Separating distinct aspects of the voluntary selection between response alternatives: N2- and P3-related BOLD responses. Neuroimage (2010) 0.86
Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. Hum Brain Mapp (2009) 0.86
Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans. Biol Psychiatry (2012) 0.85
Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res (2009) 0.85
Alterations of the early auditory evoked gamma-band response in first-degree relatives of patients with schizophrenia: hints to a new intermediate phenotype. J Psychiatr Res (2010) 0.85
A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder. Psychiatry Res (2012) 0.85
[I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci (2007) 0.84
Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study. Psychiatry Res (2007) 0.84
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study. J Psychiatr Res (2013) 0.84
Attention to emotion: auditory-evoked potentials in an emotional choice reaction task and personality traits as assessed by the NEO FFI. Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine. Psychiatry Res (2011) 0.83
Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia. World J Biol Psychiatry (2014) 0.83
EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci (2008) 0.82
Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials. Int J Neuropsychopharmacol (2008) 0.81
Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Psychiatry Res (2010) 0.80
Emotion regulation by cognitive reappraisal - the role of frontal theta oscillations. Neuroimage (2013) 0.80
Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. J Psychiatr Res (2010) 0.80
Reduced auditory evoked gamma band response and cognitive processing deficits in first episode schizophrenia. World J Biol Psychiatry (2015) 0.79
Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder - a replication study using auditory event-related P300 subcomponents. J Psychiatr Res (2007) 0.79
Event related potentials and fMRI in neuropsychopharmacology. Clin EEG Neurosci (2006) 0.79
Functional magnetic resonance imaging and treatment strategies in schizophrenia. Curr Pharm Biotechnol (2012) 0.79
The free choice whether or not to respond after stimulus presentation. Hum Brain Mapp (2009) 0.79
SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD). Eur Neuropsychopharmacol (2005) 0.79
Transcranial direct current stimulation in a patient with therapy-resistant major depression. World J Biol Psychiatry (2009) 0.78
Drug safety and efficacy evaluation of sertindole for schizophrenia. Expert Opin Drug Saf (2012) 0.78
Electrophysiological and neuropsychological analysis of a delirious state: the role of the anterior cingulate gyrus. Psychiatry Res (2005) 0.78
Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol (2008) 0.78
Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet (2008) 0.78
Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism. Clin EEG Neurosci (2007) 0.77
Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol (2006) 0.77
P300 in obsessive-compulsive disorder: source localization and the effects of treatment. J Psychiatr Res (2013) 0.77
[Neuroimaging and the neurobiology of obsessive-compulsive disorder]. Psychother Psychosom Med Psychol (2007) 0.77
Single-trial EEG-fMRI coupling of the emotional auditory early posterior negativity. Neuroimage (2012) 0.77
[Subjectively-perceived inappropriate treatment of depressed patients in general and psychiatric practice]. Z Arztl Fortbild Qualitatssich (2003) 0.76
Event-related potentials in psychiatry. Clin EEG Neurosci (2007) 0.76
Increased gamma oscillations evoked by physically salient distracters are associated with schizotypy. Brain Topogr (2014) 0.76
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology (2004) 0.76
Schizophrenia as a disorder of communication. Schizophr Res Treatment (2013) 0.75
Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice. Clin EEG Neurosci (2007) 0.75
Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4. J Psychiatr Res (2008) 0.75
Effects of Low Frequency Prefrontal Repetitive Transcranial Magnetic Stimulation on the N2 Amplitude in a GoNogo Task. PLoS One (2013) 0.75
Loudness dependence of auditory evoked potentials in patients with borderline personality disorder--impact of psychopathology. Psychiatry Res (2012) 0.75
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential study. J Clin Psychopharmacol (2010) 0.75
[Agreement in physicians' and patients' assessment of depressive disorders]. Z Arztl Fortbild Qualitatssich (2003) 0.75
[123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials. Eur Arch Psychiatry Clin Neurosci (2007) 0.75
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline. J Clin Psychiatry (2006) 0.75
Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Psychiatry Res (2007) 0.75